Department of Human Sciences, International University of Rome (UNINT); Paideia Hospital, Rome
Dr. Lucio Mango
Address:
- Via Cristoforo Colombo, 200 - 00147 Rome, Italy
Research Interests:
- Nuclear Medicine
- Oncology
- Theranostics
- PET/CT and SPECT/CT Imaging
- Radiometabolic Therapy
- Endocrinology (especially Thyroidology)
- Molecular Imaging
- Radiopharmaceutical
Biography:
Dr. Lucio Mango is a highly esteemed figure in the Italian medical community, with a distinguished career spanning decades in nuclear medicine, oncology, and endocrinology. He is a Professor at the International University of Rome (UNINT) and serves as the Director of Nuclear Medicine at Paideia Hospital. Dr. Mango is a pioneer in the application of radioisotopes for the diagnosis and therapy (theranostics) of various diseases, particularly cancer. His work has been instrumental in advancing diagnostic imaging techniques like PET and SPECT and in the development of radiometabolic therapies for thyroid cancer and neuroendocrine tumors. He is a passionate advocate for interdisciplinary collaboration and has authored numerous scientific papers and books, making significant contributions to the field of molecular imaging and therapy.
Education Details:
- Specialization in Nuclear Medicine
- Specialization in Endocrinology
- MD (Laurea in Medicina e Chirurgia), Sapienza University of Rome, Italy
Professional Background:
- Professor, International University of Rome (UNINT), Rome (Present)
- Director of Nuclear Medicine, Paideia Hospital, Rome (Present)
- Former Primary Professor of Nuclear Medicine, Sacro Cuore Catholic University, Rome
- Former Director of Nuclear Medicine, Agostino Gemelli University Policlinic, Rome
- Former President, Italian Association of Nuclear Medicine (AIMN)
Achievements:
- Knight of the Order of Merit of the Italian Republic.
- Past President of the Italian Association of Nuclear Medicine (AIMN).
- Author of over 200 scientific publications and several books.
- Pioneered the use of several radiopharmaceuticals and techniques in Italy.
Current Research Projects
His current work focuses on the application of new PET tracers for oncological imaging, theranostics in prostate cancer (PSMA), and the integration of nuclear medicine with artificial intelligence for improved diagnostics and personalized treatment planning.
Publications:
Dr. Mango has a long and distinguished publication history. His recent works and commentaries continue to explore advanced applications of nuclear medicine in oncology and other fields, reflecting his lifelong commitment to the discipline.
List of 5 Recent Publications: As a senior professor with a long career, Dr. Mango's recent publications often include reviews, book chapters, and studies on advanced clinical applications.
- Mango, L., et al. (2022). Clinical impact of early and delayed 18F-FCH PET/CT in prostate cancer patients with biochemical relapse. La Radiologia Medica, 127(8), 887-894.
- Mango, L., et al. (2020). The Added Value of 18F-Choline PET/CT in the Management of Parathyroid Adenoma. Journal of Clinical Medicine, 9(10), 3230.
- Sollini, M., Mango, L., et al. (2018). PET/CT and PET/MRI in the management of non-small cell lung cancer. Current Radiopharmaceuticals, 11(1), 15-23.
- D'Addesio, V., Mango, L., et al. (2017). The Role of 18F-FDG PET/CT in Hodgkin Lymphoma. In PET/CT in Hodgkin Lymphoma. Springer, Cham.
- Caldarescu, I., Mango, L., et al. (2016). Role of PET-CT in staging and restaging of patients with Hodgkin’s lymphoma. Revista de Chirurgie Oncologica a Societatii Romane de Chirurgie, 2, 111-120.
Last Updated on October 12, 2025